AI-assisted, human-published

07/10/2025 /M & A

Tandym Group Acquires Entitech Solutions to Expand Service Portfolio

pills  medicine  prescription  healthcare  medical  health  medication  pharmaceutical  treatment  antibiotics  painkillers  dosage
AI-assisted, human-published

Tandym Group, a leader in specialized solutions for healthcare, life sciences, technology, and professional services industries, has announced the acquisition of Entitech Solutions. The move aligns with Tandym's vision to broaden its service portfolio and extend the capabilities of Tandym Catalyst™, its AI-enabled technology platform. This acquisition represents Tandym's commitment to expanding its service portfolio to provide comprehensive workforce and technology solutions.

 

Entitech brings specialized expertise in strategy, clinical data harmonization, and system integration services to pharmaceutical and biotech companies. The integration of Entitech into Tandym is expected to deliver integrated solutions to the healthcare and life sciences industries, creating new opportunities for innovation and growth. Entitech, recognized globally for its expertise in Structured Component Authoring (SCA), will benefit from Tandym's extensive resources and investment in the Tandym Catalyst™ platform to accelerate growth and provide greater value to healthcare and life sciences companies.

 

 Tandym Group is backed by Mill Rock Capital, a growth and operations-oriented private investment firm, and ICG, a global alternative asset manager. Akin Gump Strauss Hauer & Feld LLP served as legal advisor to Tandym.

 

Read more about the acquisition here

 

Featured










Latest headlines







join us

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here

©2023 VentureCapital.com